“…To minimize or eliminate this risk, it is necessary to ensure that the final product is in liquid form in cases in which it is possible to enter the systemic circulation and pass through a double filter (filter in filter) in the obtained liquid. 3 For this purpose, the indication-based protocols (IPs) defined by Copcu and Oztan should be followed in mechanical stromal-cell transfer. 4 If the final product is to be obtained in liquid form, the condensed fat should be diluted with an appropriate liquid (saline, ringer, platelet-poor-plasma, etc.)…”